Role of surgical revascularization in diabetic patients with coronary artery disease

References

• Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabet. Care 20(9), 1396–1402 (1997).
   PubMed Web of Science ®Google Scholar
• Bjork S. The cost of diabetes and diabetes care. Diabet. Res. Clin. Pract. 54(Suppl. 1) S13–S18 (2001).
   PubMed Web of Science ®Google Scholar
• Boyle JP, Honeycutt AA, Narayan KMV et al. Projection of Diabetes Burden Through 2050: impact of changing demography and disease prevalence in the US. Diabet. Care 24(11), 1936–1940 (2001).
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Ford ESM, Bowman BA et al. Diabetes trends in the USA: 1990–1998. Diabet. Care 23(9), 1278–1283 (2000).
   PubMed Web of Science ®Google Scholar
• National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Statistics. National Institutes of Health Publication 04-3892, Bethesda, MD, USA (2004).
   Google Scholar
• Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk-Factor Intervention Trial. Diabet. Care 16(2), 434–444 (1993).
   PubMed Web of Science ®Google Scholar
• Krolewski AS, Kosinski EJ, Warram JH et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am. J. Cardiol. 59(8), 750–755 (1987).
   PubMed Web of Science ®Google Scholar
• Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br. Med. J. Clin. Res. 294(6588), 1651–1654 (1987).
   PubMed Web of Science ®Google Scholar
• Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of Type I diabetes mellitus and its complications. N. Engl. J. Med. 317(22), 1390–1398 (1987).
   PubMed Web of Science ®Google Scholar
• Kannel WB. Lipids, diabetes and coronary heart disease: insights from the Framingham Study. Am. Heart J. 110(5), 1100–1107 (1985).
   PubMed Web of Science ®Google Scholar
• Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with Type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339(4), 229–234 (1998).
   PubMed Web of Science ®Google Scholar
• Stone PH, Muller JE, Hartwell T et al. The effect of diabetes mellitus on prognosis and serial left-ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left-ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J. Am. Col. Cardiol. 14(1), 49–57 (1989).
   PubMed Web of Science ®Google Scholar
• Savage MP, Krolewski AS, Kenien GG et al. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am. J. Cardiol. 62(10 Pt 1), 665–669 (1988).
   PubMed Web of Science ®Google Scholar
• Miettinen H, Lehto S, Salomaa V et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabet. Care 21(1), 69–75 (1998).
   PubMed Web of Science ®Google Scholar
• Eagle KA, Guyton RA, Davidoff R et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J. Am. Col. Cardiol. 44(5), 1146–1154 (2004).
   Web of Science ®Google Scholar
• Anonymous. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 68(5), 939–950 (1983).
   PubMed Web of Science ®Google Scholar
• Anonymous. 11-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. N. Engl. J. Med. 311(21), 1333–1339 (1984).
   PubMed Web of Science ®Google Scholar
• Anonymous. Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris. European Coronary Surgery Study Group. Lancet 2(8309), 1173–1180 (1982).
   PubMed Web of Science ®Google Scholar
• Norris RM, Agnew TM, Brandt PW et al. Coronary surgery after recurrent myocardial infarction: progress of a trial comparing surgical with nonsurgical management for asymptomatic patients with advanced coronary disease. Circulation 63(4), 785–792 (1981).
   PubMed Web of Science ®Google Scholar
• Mathur VS, Guinn GA. Prospective randomized study of the surgical therapy of stable angina. Cardiovasc. Clin. 8(2), 131–144 (1977).
   PubMedGoogle Scholar
• Kloster FE, Kremkau EL, Ritzmann LW et al. Coronary bypass for stable angina: a prospective randomized study. N. Engl. J. Med. 300(4), 149–157 (1979).
   PubMed Web of Science ®Google Scholar
• Yusuf S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344(8922), 563–570 (1994) Erratum: Lancet 344(8934), 1446 (1994).
   PubMed Web of Science ®Google Scholar
• Alderman EL, Bourassa MG, Cohen LS et al. 10-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study (CASS). Circulation 82(5), 1629–1646 (1990).
   PubMed Web of Science ®Google Scholar
• Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation 54(Suppl. 6) (1976).
   PubMedGoogle Scholar
• Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N. Engl. J. Med. 312(26), 1665–1671 (1985).
   PubMed Web of Science ®Google Scholar
• Peduzzi P, Hultgren HN. Effect of medical vs. surgical treatment on symptoms in stable angina pectoris. The Veterans Administration Cooperative Study of surgery for coronary arterial occlusive disease. Circulation 60(4), 888–900 (1979).
   PubMed Web of Science ®Google Scholar
• Mock MB, Fisher LD, Holmes DR Jr. et al. Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left-ventricular dysfunction: a Coronary Artery Surgery Study Registry Study. Am. J. Cardiol. 61(15), 1198–1203 (1988).
   PubMed Web of Science ®Google Scholar
• Weiner DA, Ryan TJ, McCabe CH et al. The role of exercise testing in identifying patients with improved survival after coronary artery bypass surgery. J. Am. Col. Cardiol. 8(4), 741–748 (1986).
   PubMed Web of Science ®Google Scholar
• Davies RF, Goldberg AD, Forman S et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 95(8), 2037–2043 (1997).
   PubMed Web of Science ®Google Scholar
• Detre KM, Lombardero MS, Brooks MM et al. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N. Engl. J. Med. 342(14), 989–997 (2000).
   PubMed Web of Science ®Google Scholar
• Anonymous. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J. Am. Col. Cardiol. 35(5), 1122–1129 (2000).
   PubMed Web of Science ®Google Scholar
• Detre KM, Holubkov R. Coronary revascularization on balance. Robert L Frye lecture. Mayo Clin. Proc. 77(1), 72–82 (2002).
   PubMed Web of Science ®Google Scholar
• Van Belle E, Ketelers R, Bauters C et al. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty. Circulation 103(9), 1218–1224 (2001).
   PubMed Web of Science ®Google Scholar
• Carson JL, Scholz PM, Chen AY et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J. Am. Col. Cardiol. 40(3), 418–423 (2002).
   PubMed Web of Science ®Google Scholar
• Furnary AP, Gao G, Grunkemeier GL et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 125(5), 1007–1021 (2003).
   PubMed Web of Science ®Google Scholar
• Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann. Thorac. Surg. 67(2), 352–360 (1999).
   PubMed Web of Science ®Google Scholar
• McAlister FA, Man J, Bistritz L, Amad H, Tandon P. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabet. Care 26(5), 1518–1524 (2003).
   PubMed Web of Science ®Google Scholar
• Zerr KJ, Furnary AP, Grunkemeier GL et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann. Thorac. Surg. 63(2), 356–361 (1997).
   PubMed Web of Science ®Google Scholar
• Anonymous. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N. Engl. J. Med. 335(4), 217–225 (1996).
   PubMed Web of Science ®Google Scholar
• Calafiore AM, Di Mauro M, Di Giammarco G et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J. Thorac. Cardiovasc. Surg. 125(1), 144–154 (2003).
   PubMed Web of Science ®Google Scholar
• Leavitt BJ SL, Maloney C, Clough RA et al. Northern New England Cardiovascular Disease Study Group. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 110(11 Suppl. 1), II41–I144 (2004).
   PubMed Web of Science ®Google Scholar
• Alderman EL, Kip KE, Whitlow PL et al. Native coronary disease progression exceeds failed revascularization as cause of angina after 5 years in the Bypass Angioplasty Revascularization Investigation (BARI). J. Am. Col. Cardiol. 44(4), 766–774 (2004).
   PubMed Web of Science ®Google Scholar
• Campeau L, Enjalbert M, Lesperance J et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N. Engl. J. Med. 311(21), 1329–1332 (1984).
   PubMed Web of Science ®Google Scholar
• Campeau L, Enjalbert M, Lesperance J et al. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation 68(3 Pt 2) (1983).
   PubMedGoogle Scholar
• Chesebro JH, Fuster V, Elveback LR et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N. Engl. J. Med. 310(4), 209–214 (1984).
   PubMed Web of Science ®Google Scholar
• Lorenz RL, Schacky CV, Weber M et al. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation. Lancet 1(8389), 1261–1264 (1984).
   PubMed Web of Science ®Google Scholar
• Goldman S, Copeland J, Moritz T et al. Internal mammary artery and saphenous vein-graft patency. Effects of aspirin. Circulation 82(Suppl. 5) (1990).
   PubMedGoogle Scholar
• Mangano DT, Multicenter Study of Perioperative Ischemia Research G. Aspirin and mortality from coronary bypass surgery. N. Engl. J. Med. 347(17), 1309–1317 (2002).
   PubMed Web of Science ®Google Scholar
• Anonymous. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The Post Coronary Artery Bypass Graft Trial Investigators. N. Engl. J. Med. 336(3), 153–162 (1997).
   PubMed Web of Science ®Google Scholar
• Brophy JM, Bourgault C, Brassard P. The use of cholesterol-lowering medications after coronary revascularization. Canadian Med. Assoc. J. 169(11), 1153–1157 (1153).
   Google Scholar
• Foody JM, Ferdinand FD, Galusha D et al. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction. Circulation 108(1), 9 (2003).
   PubMedGoogle Scholar
• Mann MJ, Whittemore AD, Donaldson MC et al. Ex vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 354(9189), 1493–1498 (1997).
   Web of Science ®Google Scholar
• Mann MJ. Transcription factor decoys for the prevention of vein bypass graft failure. Am. J. Cardiovasc. Drug. 3(2), 79–85 (2003).
   PubMedGoogle Scholar
• Zulli A, Hare DL, Horrigan M, Buxton BF. The resistance of the IMA to atherosclerosis might be associated with its higher eNOS, ACE and ET-A receptor immunoreactivity. Arterioscler. Thromb. Vasc. Biol. 23(7), 1 (2003).
   Google Scholar
• Gaudino M, Toesca A, Maggiano N, Pragliola C, Possati G. Localization of nitric oxide synthase Type III in the internal thoracic and radial arteries and the great saphenous vein: a comparative immunohistochemical study. J. Thorac. Cardiovasc. Surg. 125(6), 1510–1515 (2003).
   PubMed Web of Science ®Google Scholar
• Barner HB, Standeven JW, Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass. J. Thorac. Cardiovasc. Surg. 90(5), 668–675 (1985).
   PubMed Web of Science ®Google Scholar
• Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann. Thorac. Surg. 77(1), 93–101 (2004).
   PubMed Web of Science ®Google Scholar
• Loop FD, Lytle BW, Cosgrove DM et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N. Engl. J. Med. 314(1), 1–6 (1986).
   PubMed Web of Science ®Google Scholar
• Schwartz L, Kip KE, Frye RL et al. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 106(21), 2652–2658 (2002).
   PubMed Web of Science ®Google Scholar
• Whitlow PL, Dimas AP, Bashore TM et al. Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI). J. Am. Col. Cardiol. 34(6), 1750–1759 (1999).
   PubMed Web of Science ®Google Scholar
• Anonymous. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96(6), 1761–1769 (1997).
   PubMed Web of Science ®Google Scholar
• Buxton BF, Komeda M, Fuller JA, Gordon I. Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery. Risk-adjusted survival. Circulation 98(Suppl. 19), 10 (1998).
   Google Scholar
• Lytle BW, Blackstone EH, Loop FD et al. Two internal thoracic artery grafts are better than one. J. Thorac. Cardiovasc. Surg. 117(5), 855–872 (1999).
   PubMed Web of Science ®Google Scholar
• Matsa M, Paz Y, Gurevitch J et al. Bilateral skeletonized internal thoracic artery grafts in patients with diabetes mellitus. J. Thorac. Cardiovasc. Surg. 121(4), 668–674 (2001).
   PubMed Web of Science ®Google Scholar
• Calafiore AM, Vitolla G, Iaco AL et al. Bilateral internal mammary artery grafting: midterm results of pedicled versus skeletonized conduits. Ann. Thorac. Surg. 67(6), 1637–1642 (1999).
   PubMed Web of Science ®Google Scholar
• Dion R, Glineur D, Derouck D et al. Long-term clinical and angiographic follow-up of sequential internal thoracic artery grafting. Euro. J. Cardio Thorac. Surg. 17(4), 407–414 (2000).
   Google Scholar
• Tector AJ, Kress DC, Downey FX, Schmahl TM. Complete revascularization with internal thoracic artery grafts. Semin. Thorac. Cardiovasc. Surg. 8(1), 29–41 (1996).
   PubMedGoogle Scholar
• Tector AJ, McDonald ML, Kress DC, Downey FX, Schmahl TM. Purely internal thoracic artery grafts: outcomes. Ann. Thorac. Surg. 72(2), 450–455 (2001).
   PubMed Web of Science ®Google Scholar
• Sauvage LR, Rosenfeld JG, Roby PV et al. Internal thoracic artery grafts for the entire heart at a mean of 12 years. Ann. Thorac. Surg. 75(2), 501–504 (2003).
   PubMed Web of Science ®Google Scholar
• Barner HB, Sundt TM 3rd, Bailey M, Zang Y. Midterm results of complete arterial revascularization in more than 1,000 patients using an internal thoracic artery/radial artery T graft. Ann. Surg. 234(4), 447–452 (2001).
   PubMed Web of Science ®Google Scholar
• Lev-Ran O, Mohr R, Pevni D et al. Bilateral internal thoracic artery grafting in diabetic patients: short-term and long-term results of a 515-patient series. J. Thorac. Cardiovasc. Surg. 127(4), 1145–1150 (2004).
   PubMed Web of Science ®Google Scholar
• Lev-Ran O, Braunstein R, Nesher N et al. Bilateral versus single internal thoracic artery grafting in oral-treated diabetic subsets: comparative seven-year outcome analysis. Ann. Thorac. Surg. 77(6), 2039–2045 (2004).
   PubMed Web of Science ®Google Scholar
• Lev-Ran O, Mohr R, Amir K et al. Bilateral internal thoracic artery grafting in insulin-treated diabetics: should it be avoided? Ann. Thorac. Surg. 75(6), 1872–1877 (2003).
   PubMed Web of Science ®Google Scholar
• Muneretto C, Negri A, Manfredi J et al. Safety and usefulness of composite grafts for total arterial myocardial revascularization: a prospective randomized evaluation. J. Thorac. Cardiovasc. Surg. 125(4), 826–835 (2003).
   PubMed Web of Science ®Google Scholar
• Muneretto C, Bisleri G, Negri A et al. Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery. Circulation 108(1), 9 (2003).
   PubMedGoogle Scholar
• Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 301(2), 61–68 (1979).
   PubMed Web of Science ®Google Scholar
• Kip KE, Faxon DP, Detre KM et al. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 94(8), 1818–1825 (1996).
   PubMed Web of Science ®Google Scholar
• Stein B, Weintraub WS, Gebhart SP et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 91(4), 979–989 (1995).
   PubMed Web of Science ®Google Scholar
• Van Belle E, Chmait A, Bauters C, Lablanche JM. Angioplasty in the diabetic patient. J. Invas. Cardiol. 16(1), 23–27 (2004).
   PubMedGoogle Scholar
• Rozenman Y, Sapoznikov D, Mosseri M et al. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. J. Am. Col. Cardiol. 30(6), 1420–1425 (1997).
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Marso SP, Lincoff AM et al. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J. Am. Col. Cardiol. 35(4), 922–928 (2000).
   PubMed Web of Science ®Google Scholar
• Van Belle E, Bauters C, Hubert E et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96(5), 1454–1460 (1997).
   PubMed Web of Science ®Google Scholar
• Van Belle E, Perie M, Braune D et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J. Am. Col. Cardiol. 40(3), 410–417 (2002).
   PubMed Web of Science ®Google Scholar
• Kelsey SF. Patients with diabetes did better with coronary bypass graft surgery than with percutaneous transluminal coronary angioplasty: was this BARI finding real? Am. Heart J. 138(5 Pt 1), S387–S393 (1999).
   PubMed Web of Science ®Google Scholar
• King SB 3rd, Lembo NJ, Weintraub WS et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N. Engl. J. Med. 331(16), 1044–1050 (1994).
   PubMed Web of Science ®Google Scholar
• King SB 3rd, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. 8-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J. Am. Col. Cardiol. 35(5), 1116–1121 (2000).
   PubMed Web of Science ®Google Scholar
• Kurbaan AS, Bowker TJ, Ilsley CD et al. Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am. J. Cardiol. 87(8), 947–950 (2001).
   PubMed Web of Science ®Google Scholar
• Henderson RA, Pocock SJ, Sharp SJ et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet 352(9138), 1419–1425 (1998).
   PubMed Web of Science ®Google Scholar
• Niles NW, McGrath PD, Malenka D et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J. Am. Col. Cardiol. 37(4), 1008–1015 (2001).
   PubMed Web of Science ®Google Scholar
• Barsness GW, Peterson ED, Ohman EM et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 96(8), 2551–2556 (1997).
   PubMed Web of Science ®Google Scholar
• Abizaid A, Costa MA, Centemero M et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 104(5), 533–538 (2001).
   PubMed Web of Science ®Google Scholar
• Legrand VM, Serruys PW, Unger F et al. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 109(9), 1114–1120 (2004).
   PubMed Web of Science ®Google Scholar
• SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomized controlled trial. Lancet 360(9338), 965–970 (2002).
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Rodriguez Alemparte M, Baldi J et al. Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study. Heart 89(2), 184–188 (2003).
   PubMed Web of Science ®Google Scholar
• Locker C, Mohr R, Lev-Ran O et al. Comparison of bilateral thoracic artery grafting with percutaneous coronary interventions in diabetic patients. Ann. Thorac. Surg. 78, 471–475 (2004).
   PubMed Web of Science ®Google Scholar
• Hlatky MA, Boothroyd D, Melsop KA et al. Medical Costs and Quality of Life 10 to 12 Years After Randomization to Angioplasty or Bypass Surgery for Multivessel Coronary Artery Disease. Circulation 110, 1960–1966 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang Z, Mahoney EM, Stables RH et al. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial. Circulation 108(14), 1694–1700 (1694).
   Google Scholar
• Hlatky MA, Rogers WJ, Johnstone I et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N. Engl. J. Med. 336(2), 92–99 (1997).
   PubMed Web of Science ®Google Scholar
• Sobel BE, Frye R, Detre KM, Bypass Angioplasty Revascularization Investigation 2 Diabetes T. Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation 107(4), 636–642 (2003).
   PubMed Web of Science ®Google Scholar
• Smith D. The CARDia trial protocol. Heart 89(10), 1125–1126 (2003).
   PubMed Web of Science ®Google Scholar